Mar 31, 2023

Novanta Q1 2023 Earnings Report

Novanta's first quarter results for 2023 showed revenue growth and solid performance, driven by strong growth in medical end-markets.

Key Takeaways

Novanta reported a 7% increase in GAAP revenue to $219 million for the first quarter of 2023. The company's strong performance was driven by growth in medical end-markets and effective execution by the teams.

GAAP Revenue increased 7% to $219 million.

GAAP Net Income was $18 million.

Adjusted Earnings Per Share reached $0.74.

Adjusted EBITDA amounted to $47 million.

Total Revenue
$219M
Previous year: $204M
+7.3%
EPS
$0.74
Previous year: $0.73
+1.4%
Adjusted EBITDA
$47M
Previous year: $43.6M
+7.8%
Gross Profit
$97.6M
Previous year: $90.3M
+8.1%
Cash and Equivalents
$82.7M
Previous year: $98.8M
-16.3%
Free Cash Flow
$6.63M
Previous year: $5.04M
+31.5%
Total Assets
$1.23B
Previous year: $1.21B
+1.6%

Novanta

Novanta

Forward Guidance

For the second quarter of 2023, the Company expects GAAP revenue of approximately $222 million to $225 million. The Company expects Adjusted EBITDA to be in the range of $47 million to $49 million and Adjusted Diluted EPS to be in the range of $0.70 to $0.74.